Filing Details

Accession Number:
0001209191-15-081520
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-11-20 16:09:24
Reporting Period:
2015-11-18
Filing Date:
2015-11-20
Accepted Time:
2015-11-20 16:09:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1215126 G Margaret Mcglynn C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-11-18 12,500 $57.27 13,588 No 4 M Direct
Common Stock Disposition 2015-11-18 12,500 $130.15 1,088 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2015-11-18 12,500 $0.00 12,500 $57.27
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2021-05-11 No 4 M Direct
Footnotes
  1. Transaction made pursuant to Ms. McGlynn's company approved trading plan under Rule 10b5-1.
  2. Open market sales reported on this line occurred at a weighted average price of $130.15 (range $130.00 to $130.55).
  3. Ms. McGlynn undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  4. Fully vested.